<scp>miR</scp>‐222‐5p promotes dysfunction of human vascular smooth muscle cells by targeting <scp>RB1</scp>

Abstract

miR-222-5p accelerates the dysfunction of VSMCs and promotes pathological changes and lipid deposition in ApoE-knockout mice by targeting RB1. The study may provide novel therapeutic targets for AS.